Divis Laboratories Ltd | DIVI - Cost Of Sales

Stock Price
5,888.50
Daily Change
38.50 0.66%
Monthly
-6.97%
Yearly
9.33%
Q2 Forecast
5,728.83

Divis Laboratories Ltd reported INR10.63B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
Aurobindo Pharma INR 39.46B 6.07B Dec/2025
Avita Medical AUD 3.3M 166K Dec/2025
Divis Laboratories Ltd INR 10.63B 1.23B Dec/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Lupin INR 21.91B 495.5M Dec/2025
Moderna USD 452M 245M Dec/2025
Organon & Co USD 745M 25M Sep/2025
Revvity USD 350.4M 26.05M Dec/2025
Tilray USD 164.37M 8.41M Sep/2025
Viatris USD 2.56B 167.3M Dec/2025
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025